DAVERMAN JAMES E 4
4 · COLLAGENEX PHARMACEUTICALS INC · Filed Oct 7, 2003
Insider Transaction Report
Form 4
DAVERMAN JAMES E
Director
Transactions
- Sale
Common Stock
2003-10-06$10.00/sh−41,302$413,020→ 640,650 total(indirect: By Marquette Venture Partners II, L.P.) - Sale
Common Stock
2003-10-03$10.00/sh−300,000$3,000,000→ 640,650 total(indirect: By Marquette Venture Partners II, L.P.)
Footnotes (3)
- [F1]The sale of such shares of Common Stock was effected by Marquette Venture Partners II, L.P.
- [F2]Includes 1,006 shares of Common Stock held by MVP II Affiliates Fund, L.P., 584,644 shares of Common Stock held by Marquette Venture Partners II, L.P. and 55,000 shares of Common Stock held by Mr. Daverman individually. Does not include 98,269 shares of Common Stock issuable upon conversion of 9,722 shares of the Issuer's Series D Preferred Stock held by Marquette Venture Partners II, L.P. and 2,810 shares of Common Stock issuable upon conversion of 278 shares of the Issuer's Series D Preferred Stock held by MVP II Affiliates Fund, L.P.
- [F3]Mr. Daverman is a member of the Issuer's Board of Directors, is President of Marquette Management Partners, LLC, and a general partner of Marquette General II, L.P., the general partner of Marquette Venture Partners II, L.P. and MVP II Affiliates Fund, L.P. and, as such, has the power to vote or direct the vote of and to dispose of or direct the disposition of the shares owned by Marquette Venture Partners II, L.P. and MVP II Affiliates Fund, L.P. Mr. Daverman expressly disclaims beneficial ownership of such shares, except as to his proportionate interest in Marquette Venture Partners II, L.P. and MVP II Affiliates Fund, L.P.